Recombinant multi-species SIRT3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SIRT3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
SIRT3 encodes a member of the sirtuin family of class III histone deacetylases, homologs to the yeast Sir2 protein. The encoded protein is found exclusively in mitochondria, where it can eliminate reactive oxygen species, inhibit apoptosis, and prevent the formation of cancer cells. SIRT3 has far-reaching effects on nuclear gene expression, cancer, cardiovascular disease, neuroprotection, aging, and metabolic control. [provided by RefSeq, May 2019]
The Alternative Names of target: 2310003L23Rik,NAD-dependent protein deacetylase sirtuin-3,NAD-dependent protein delactylase sirtuin-3,Regulatory protein SIR2 homolog 3,SIR2-like protein 3,SIR2L3,SIRT3,Sir2l3,Sirt3,hSIRT3,mitochondrial
Go
to SIRT3 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T91959-Ag-1/ GM-Tg-hg-T91959-Ag-2 | Human SIRT3 protein | Human |
| GM-Tg-rg-T91959-Ag-1/ GM-Tg-rg-T91959-Ag-2 | Rat SIRT3 protein | Rat |
| GM-Tg-mg-T91959-Ag-1/ GM-Tg-mg-T91959-Ag-2 | Mouse SIRT3 protein | Mouse |
| GM-Tg-cynog-T91959-Ag-1/ GM-Tg-cynog-T91959-Ag-2 | Cynomolgus/Rhesus macaque SIRT3 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T91959-Ag-1/ GM-Tg-felg-T91959-Ag-2 | Feline SIRT3 protein | Feline |
| GM-Tg-cang-T91959-Ag-1/ GM-Tg-cang-T91959-Ag-2 | Canine SIRT3 protein | Canine |
| GM-Tg-bovg-T91959-Ag-1/ GM-Tg-bovg-T91959-Ag-2 | Bovine SIRT3 protein | Bovine |
| GM-Tg-equg-T91959-Ag-1/ GM-Tg-equg-T91959-Ag-2 | Equine SIRT3 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T91959-Ag-1/ GM-Tg-hg-T91959-Ag-2;
GM-Tg-rg-T91959-Ag-1/ GM-Tg-rg-T91959-Ag-2;
GM-Tg-mg-T91959-Ag-1/ GM-Tg-mg-T91959-Ag-2; GM-Tg-cynog-T91959-Ag-1/ GM-Tg-cynog-T91959-Ag-2; GM-Tg-felg-T91959-Ag-1/ GM-Tg-felg-T91959-Ag-2; GM-Tg-cang-T91959-Ag-1/ GM-Tg-cang-T91959-Ag-2; GM-Tg-bovg-T91959-Ag-1/ GM-Tg-bovg-T91959-Ag-2; GM-Tg-equg-T91959-Ag-1/ GM-Tg-equg-T91959-Ag-2 |
| Products Name | SIRT3 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | SIRT3 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SIRT3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.